Addressing common barriers to adherence requires socioeconomic health system processes, community support, and focused communication and education strategies.
Date: Monday, August 17, 2020
Time: 12:00 pm
– 1:00 pm ET
Join us and hear from leading experts: Nancy D’Hondt RPh, CDCES, FADCES, Clinical Pharmacist Ascension Health, St. John Hospital and Medical Center, Joshua J. Joseph M.D., Assistant Professor of Medicine in the Division of Endocrinology, Diabetes and Metabolism at The Ohio State University Wexner Medical Center, Suzanne Steinbaum, M.D, Director of Women’s Heart Health of Lenox Hill Hospital in New York City, and* Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP*, Associate Professor and Clinical Pharmacist, Touro University California College of Osteopathic Medicine, on how they address these common barriers in the management of type 2 diabetes and CVD risk.
Clipper Young, PharmD, MPH, CDCES, BC-ADM, BCGP
Joshua J. Joseph, M.D.
Suzanne Steinbaum, M.D.
Nancy D’Hondt, RPh, CDCES, FADCES
